Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_assertion type Assertion NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_head.
- NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_assertion description "[In contrast, 28% of patients with T-ALL were classified in the MRD-based high-risk group compared to only 11% of patients with precursor B-ALL (P =.02), and the RFS rates were 0% and 25%, respectively (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_provenance.
- NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_assertion evidence source_evidence_literature NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_provenance.
- NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_assertion SIO_000772 12036866 NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_provenance.
- NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_assertion wasDerivedFrom befree-20140225 NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_provenance.
- NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_assertion wasGeneratedBy ECO_0000203 NP461121.RAi6qvvDCHq3qAHcTSs9IQuBJOUWZ_6O8XnyV9C2Xg-2Y130_provenance.